BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

825 related articles for article (PubMed ID: 31880253)

  • 1. Antidiabetic Activity of Dihydropyrimidine Scaffolds and Structural Insight by Single Crystal X-ray Studies.
    Bairagi KM; Younis NS; Emeka PM; Sangtani E; Gonnade RG; Venugopala KN; Alwassil OI; Khalil HE; Nayak SK
    Med Chem; 2020; 16(7):996-1003. PubMed ID: 31880253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Larvicidal study of tetrahydropyrimidine scaffolds against Anopheles arabiensis and structural insight by single crystal X-ray studies.
    Bairagi KM; Venugopala KN; Mondal PK; Gleiser RM; Chopra D; García D; Odhav B; Nayak SK
    Chem Biol Drug Des; 2018 Dec; 92(6):1924-1932. PubMed ID: 29923688
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulinotropic action of 2, 4-dinitroanilino-benzoic acid through the attenuation of pancreatic beta-cell lesions in diabetic rats.
    Jahan H; Choudhary MI; Manzoor M; Khan KM; Perveen S; Atta-Ur-Rahman
    Chem Biol Interact; 2017 Aug; 273():237-244. PubMed ID: 28625491
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structural characterization and in vivo anti-diabetic evaluation of some new sulfonylurea derivatives in normal and silicate coated nanoparticle forms as anti-hyperglycemic agents.
    Sroor FM; Abbas SY; Basyouni WM; El-Bayouki KAM; El-Mansy MF; Aly HF; Ali SA; Arafa AF; Haroun AA
    Bioorg Chem; 2019 Nov; 92():103290. PubMed ID: 31561109
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design and synthesis of novel imidazoline derivatives with potent antihyperglycemic activity in a rat model of type 2 diabetes.
    Crane L; Anastassiadou M; El Hage S; Stigliani JL; Baziard-Mouysset G; Payard M; Leger JM; Bizot-Espiard JG; Ktorza A; Caignard DH; Renard P
    Bioorg Med Chem; 2006 Nov; 14(22):7419-33. PubMed ID: 16889967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and synthesis of 3,5-diarylisoxazole derivatives as novel class of anti-hyperglycemic and lipid lowering agents.
    Kumar A; Maurya RA; Sharma S; Ahmad P; Singh AB; Tamrakar AK; Srivastava AK
    Bioorg Med Chem; 2009 Jul; 17(14):5285-92. PubMed ID: 19500993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-diabetic effect of a novel N-Trisaccharide isolated from Cucumis prophetarum on streptozotocin-nicotinamide induced type 2 diabetic rats.
    Kavishankar GB; Lakshmidevi N
    Phytomedicine; 2014 Apr; 21(5):624-30. PubMed ID: 24462215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction of oxidative stress by a new low-molecular-weight antioxidant improves metabolic alterations in a nonobese mouse diabetes model.
    Novelli M; D'Aleo V; Lupi R; Paolini M; Soleti A; Marchetti P; Masiello P
    Pancreas; 2007 Nov; 35(4):e10-7. PubMed ID: 18090226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antihyperglycemic activity of 2-methyl-3,4,5-triaryl-1H-pyrroles in SLM and STZ models.
    Goel A; Agarwal N; Singh FV; Sharon A; Tiwari P; Dixit M; Pratap R; Srivastava AK; Maulik PR; Ram VJ
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1089-92. PubMed ID: 14980641
    [TBL] [Abstract][Full Text] [Related]  

  • 10. GLP-1 Targeted Novel 3-phenyl-7-hydroxy Substituted Coumarins Mitigate STZ-induced Pancreatic Damage and Improve Glucose Homeostasis in OGTT Method.
    Gupta MK; Srivastava R; Kumar S; Varshney KK; Singh H
    Protein Pept Lett; 2022; 29(11):979-992. PubMed ID: 36043778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The modulatory role of prime identified compounds in the bioactive fraction of Homalium zeylanicum in high-fat diet fed-streptozotocin-induced type 2 diabetic rats.
    Rout D; Chandra Dash U; Kanhar S; Swain SK; Sahoo AK
    J Ethnopharmacol; 2020 Oct; 260():113099. PubMed ID: 32535241
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A murine model of type 2 diabetes mellitus developed using a combination of high fat diet and multiple low doses of streptozotocin treatment mimics the metabolic characteristics of type 2 diabetes mellitus in humans.
    Nath S; Ghosh SK; Choudhury Y
    J Pharmacol Toxicol Methods; 2017; 84():20-30. PubMed ID: 27773844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypolipidemic and hypoglycemic activities of a oleanolic acid derivative from Malva parviflora on streptozotocin-induced diabetic mice.
    Gutiérrez RMP
    Arch Pharm Res; 2017 May; 40(5):550-562. PubMed ID: 27943105
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improvement in glucose-induced insulin secretion in diabetic rats after long-term gliclazide treatment: a comparative study using different models of non-insulin-dependent diabetes mellitus induced by neonatal streptozotocin.
    Portha B; Serradas P
    Am J Med; 1991 Jun; 90(6A):15S-21S. PubMed ID: 1831320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2'-Hydroxymatteucinol, a new C-methyl flavanone derivative from Matteccia orientalis; potent hypoglycemic activity in streptozotocin (STZ)-induced diabetic rat.
    Basnet P; Kadota S; Shimizu M; Xu HX; Namba T
    Chem Pharm Bull (Tokyo); 1993 Oct; 41(10):1790-5. PubMed ID: 8281576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and synthesis of hydrazinecarbothioamide sulfones as potential antihyperglycemic agents.
    Aly AA; Hassan AA; Makhlouf MM; Alshammari MB; Mohamed Naguib Abdel Hafez S; Refaie MMM; Bräse S; Nieger M; Ramadan M
    Arch Pharm (Weinheim); 2021 May; 354(5):e2000336. PubMed ID: 33410162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, characterization, and antihyperglycemic activity of novel oxazolidine derivatives.
    Selvam TP; Kumar PV; Ramu P; Kumar AS
    Arch Pharm Res; 2011 Jun; 34(6):887-91. PubMed ID: 21725808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of an alternative non-obese non-genetic rat model of type 2 diabetes using caffeine and streptozotocin.
    Naidoo P; Islam MS
    Pharmacol Rep; 2014 Aug; 66(4):585-93. PubMed ID: 24948058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, Synthesis, Characterization and in vivo Antidiabetic Activity Evaluation of Some Chalcone Derivatives.
    Welday Kahssay S; Hailu GS; Taye Desta K
    Drug Des Devel Ther; 2021; 15():3119-3129. PubMed ID: 34305396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of compound K on hyperglycemia and insulin resistance in rats with type 2 diabetes mellitus.
    Jiang S; Ren D; Li J; Yuan G; Li H; Xu G; Han X; Du P; An L
    Fitoterapia; 2014 Jun; 95():58-64. PubMed ID: 24613802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.